Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Chemotherapy-induced focal hepatopathy in patients with gastrointestinal malignancy: gadoxetic acid--enhanced and diffusion-weighted MR imaging with clinical-pathologic correlation.

Han NY, Park BJ, Sung DJ, Kim MJ, Cho SB, Lee CH, Jang YJ, Kim SY, Kim DS, Um SH, Won NH, Yang KS.

Radiology. 2014 May;271(2):416-25. doi: 10.1148/radiol.13131810. Epub 2014 Jan 16.

PMID:
24475862
2.

Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.

Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.

Radiology. 2012 Sep;264(3):761-70. doi: 10.1148/radiol.12112517. Epub 2012 Jul 27.

PMID:
22843769
3.

Hilar cholangiocarcinoma: value of adding DW imaging to gadoxetic acid-enhanced MR imaging with MR cholangiopancreatography for preoperative evaluation.

Park MJ, Kim YK, Lim S, Rhim H, Lee WJ.

Radiology. 2014 Mar;270(3):768-76. doi: 10.1148/radiol.13130009. Epub 2013 Oct 30.

PMID:
24475800
4.

Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.

Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, Lee WJ.

Radiology. 2015 Jul;276(1):137-46. doi: 10.1148/radiol.15141350. Epub 2015 Feb 27. Erratum in: Radiology. 2015 Oct;277(1):309.

PMID:
25734551
5.

High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors: comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging.

d'Assignies G, Fina P, Bruno O, Vullierme MP, Tubach F, Paradis V, Sauvanet A, Ruszniewski P, Vilgrain V.

Radiology. 2013 Aug;268(2):390-9. doi: 10.1148/radiol.13121628. Epub 2013 Mar 26.

PMID:
23533288
6.

Diffusion-weighted and hepatobiliary phase gadoxetic acid-enhanced quantitative MR imaging for identification of complete pathologic response in colorectal liver metastases after preoperative chemotherapy.

Hosseini-Nik H, Fischer SE, Moulton CA, Karbhase G, Menezes RJ, Gallinger S, Jhaveri KS.

Abdom Radiol (NY). 2016 Feb;41(2):231-8. doi: 10.1007/s00261-015-0572-z.

PMID:
26867904
7.
8.
9.

Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.

Kang Y, Lee JM, Kim SH, Han JK, Choi BI.

Radiology. 2012 Sep;264(3):751-60. doi: 10.1148/radiol.12112308. Epub 2012 Jul 12.

PMID:
22798225
10.
11.

Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.

Radiology. 2010 Jul;256(1):151-8. doi: 10.1148/radiol.10091885.

PMID:
20574092
12.

Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging.

Parikh T, Drew SJ, Lee VS, Wong S, Hecht EM, Babb JS, Taouli B.

Radiology. 2008 Mar;246(3):812-22. doi: 10.1148/radiol.2463070432. Epub 2008 Jan 25.

PMID:
18223123
13.

Preoperative detection of small pancreatic carcinoma: value of adding diffusion-weighted imaging to conventional MR imaging for improving confidence level.

Park MJ, Kim YK, Choi SY, Rhim H, Lee WJ, Choi D.

Radiology. 2014 Nov;273(2):433-43. doi: 10.1148/radiol.14132563. Epub 2014 Jul 4.

PMID:
24991989
14.

Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.

Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI.

Eur Radiol. 2016 Jun;26(6):1808-17. doi: 10.1007/s00330-015-4005-8. Epub 2015 Sep 15.

PMID:
26373763
15.

Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.

Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.

Radiology. 2010 May;255(2):459-66. doi: 10.1148/radiol.10091388.

PMID:
20413759
16.

Diagnostic accuracy and sensitivity of diffusion-weighted and of gadoxetic acid-enhanced 3-T MR imaging alone or in combination in the detection of small liver metastasis (≤ 1.5 cm in diameter).

Kim YK, Lee MW, Lee WJ, Kim SH, Rhim H, Lim JH, Choi D, Kim YS, Jang KM, Lee SJ, Lim HK.

Invest Radiol. 2012 Mar;47(3):159-66. doi: 10.1097/RLI.0b013e31823a1495.

PMID:
22330426
17.

MR imaging in patients with suspected liver metastases: value of liver-specific contrast agent gadoxetic acid.

Lee KH, Lee JM, Park JH, Kim JH, Park HS, Yu MH, Yoon JH, Han JK, Choi BI.

Korean J Radiol. 2013 Nov-Dec;14(6):894-904. doi: 10.3348/kjr.2013.14.6.894. Epub 2013 Nov 5.

18.
19.

The effect of gadoxetic acid enhancement on lesion detection and characterisation using T₂ weighted imaging and diffusion weighted imaging of the liver.

Choi SA, Lee SS, Jung IH, Kim HA, Byun JH, Lee MG.

Br J Radiol. 2012 Jan;85(1009):29-36. doi: 10.1259/bjr/12929687. Epub 2010 Dec 1.

20.

Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.

Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.

Radiology. 2014 Jun;271(3):748-60. doi: 10.1148/radiol.14131996. Epub 2014 Feb 1.

PMID:
24588677

Supplemental Content

Support Center